| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/14/2007 | EP1343876B1 Modulators of activity of g-protein-coupled receptor kinases |
| 02/14/2007 | EP1315750B1 Cyclic peptides having melanocortin-4 receptor agonist activity |
| 02/14/2007 | EP1242452B1 Chimeric natriuretic peptides |
| 02/14/2007 | EP1206495B1 Chimeric polypeptides, method for production and uses thereof |
| 02/14/2007 | EP1200458B1 Uses of peptides derived from the cytoplasmic domain of the amyloid protein precursor (app) |
| 02/14/2007 | EP1143000B1 Screening method |
| 02/14/2007 | EP1009726B1 Fluorination of proteins and peptides for f-18 positron emission tomography |
| 02/14/2007 | CN1911958A Polypeptide for inhibiting p38 kinase activity and its application |
| 02/14/2007 | CN1911957A Series polypeptide of blood pressure lowering peptide, expression carrier, polynucleotide sequence and application |
| 02/14/2007 | CN1911956A High affinity metal nickel combined peptide and its application |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1300328C Protein hydrol ysater enriched in peptides having a carboxy termina proline residue |
| 02/14/2007 | CN1300168C Solid carrier based on linking agent for peptide and small molecular organic synthesis |
| 02/13/2007 | US7176298 Polynucleotides encoding metal ion affinity peptides and related products |
| 02/13/2007 | US7176281 Phospholipase A2-inhibitory peptide with anti-arthritic and neuroprotective activities |
| 02/13/2007 | US7176280 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use |
| 02/13/2007 | US7176279 melanocortin receptor-specific; phosphodiesterase inhibitors; erectile dysfunction |
| 02/13/2007 | US7176278 Modified transferrin fusion proteins |
| 02/13/2007 | US7176276 Antimicrobial peptide and use thereof |
| 02/13/2007 | US7176185 A di, tri or oligopeptide covalently bonded with an active agent ( therapeutical agent, contrast agent or fluorescent dye) from a side chain of the intermediate or C-terminus amino acid |
| 02/13/2007 | US7176184 Treatment for inflammatory bowel disease with a fibronectin polypeptide |
| 02/13/2007 | US7176183 Methods for treating and preventing damage to mucosal tissue |
| 02/13/2007 | US7176035 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 02/13/2007 | US7175828 Modulators of β-amyloid peptide aggregation comprising D-amino acids |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/08/2007 | WO2007016441A1 Macrocyclic peptides as hcv ns3 protease inhibitors |
| 02/08/2007 | WO2007014946A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| 02/08/2007 | WO2006064530A3 Dermorphin analogs with analgesic activity |
| 02/08/2007 | WO2005122379A3 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 02/08/2007 | WO2005032453A3 Antiviral agents for the treatment, control and prevention of infections by coronaviruses |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032432 Is able to specifically bind IL-6R and compete for the binding of IL-6 to IL-6R, to block IL-6-induced signal transduction and therefore effectively inhibits IL-6-mediated antiapoptosis and angiogenesis, and further inhibits IL-6-mediated tumor growth. |
| 02/08/2007 | US20070032431 laminin binding site |
| 02/08/2007 | US20070032430 which resemble G amphipathic helix of apolipoprotein J; atherosclerosis; stents; catheters |
| 02/08/2007 | US20070032428 Novel antimicrobial agents |
| 02/08/2007 | US20070032417 Peptides and therapeutic uses thereof |
| 02/08/2007 | US20070032412 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks |
| 02/08/2007 | US20070032411 Protein kinase signalling |
| 02/08/2007 | US20070032406 Identification of novel nogo-receptors and methods related thereto |
| 02/08/2007 | US20070031979 Protein biopolymer markers predictive of type II diabetes |
| 02/08/2007 | US20070031894 Novel nerve stem cell marker |
| 02/08/2007 | US20070031879 Novel enterokinase cleavage sequences |
| 02/08/2007 | US20070031832 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2617294A1 Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| 02/08/2007 | CA2616115A1 Coloring compositions with peptide-based dispersants and binders |
| 02/07/2007 | EP1749023A1 Convergent synthesis for kahalalide compounds |
| 02/07/2007 | CN1910284A Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 02/07/2007 | CN1910280A Form board stationary beta hair clip ring analog and use in bacteriophage exhibition |
| 02/07/2007 | CN1910198A Tumor antigens for prevention and/or treatment of cancer |
| 02/07/2007 | CN1908010A Furin enzyme inhibitor of resisting HIV-1 and preparation method thereof |
| 02/07/2007 | CN1908009A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1908008A Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173108 Comprises tyrosine phosphatase peptides for diagnosis, prevention and treatment of autoimmune diseases; immunotherapy |
| 02/06/2007 | US7173107 Glycopeptide and preparation thereof |
| 02/06/2007 | US7173012 Hypoglycaemic peptides and methods of use thereof |
| 02/06/2007 | US7173011 Radiation therapy methods |
| 02/06/2007 | US7173005 Insulin and IGF-1 receptor agonists and antagonists |
| 02/06/2007 | US7173004 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
| 02/01/2007 | WO2007013586A1 Novel peptide |
| 02/01/2007 | WO2007013358A2 Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent |
| 02/01/2007 | WO2006132530A3 Methods and means for use in diagnostics and treatment of diabetes |
| 02/01/2007 | WO2006114323A3 Orthogonally protected bifunctional amino acid |
| 02/01/2007 | WO2006103101A3 MEANS FOR THE INHIBITION OF ANTI-β1-ADRENERGIC RECEPTOR ANTIBODIES |
| 02/01/2007 | WO2005118622A3 Naturally processed measles virus peptides eluted from class ii hla molecules |
| 02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
| 02/01/2007 | US20070027303 Metal chelate complexes immobilized on solid supports for peptide preparation |
| 02/01/2007 | US20070027091 Therapy of obesity, diabetes, bulimia, atherosclerosis, hypertension, diabetes, type 2 diabetes, impaired glucose tolerance (IGT), dyspilidemia, coronary heart disease, gallbladder disease, gall stone, osteoarthritis, cancer, sexual dysfunction, and the risk of premature death; cyclic peptides |
| 02/01/2007 | US20070027088 Peptides and mimetics for reducing symptoms of toxic shock syndrome and septic shock |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026474 provides highly purified polypeptides and antibodies for use in accurate assays |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 02/01/2007 | CA2616135A1 Complement c3a derived peptides and uses thereof |
| 01/31/2007 | CN1905893A Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 01/31/2007 | CN1905892A Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/31/2007 | CN1903874A Preparation method of CYP1A2 polypeptide and antihuman CYP1A2 polypeptide antibody |
| 01/30/2007 | US7169919 Genetically engineered lipids for use in the treatment baterial infection |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169892 Wherein the lipid is conjugated to the amino terminus of the peptide by a peptide bond and the water-soluble polymer is conjugated to the carboxy terminus of the peptide by a peptide bond; for use as colloidal carriers and the like of tissue-specific drug delivery systems |
| 01/30/2007 | US7169890 New amide derivatives of deacylated ramoplanin have the same or better antinfective activity, lower hemolytic effect and better tolerability profile than ramoplanin |
| 01/30/2007 | US7169888 For inhibiting angiogenesis in a mammal; cancer therapy |
| 01/30/2007 | US7169760 Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 01/30/2007 | US7169758 Use of hepcidin as a regulator of iron homeostasis |
| 01/30/2007 | US7169756 Cyclic peptide antibiotic wherein antibiotic is a streptogramin Type B derivative and is characterized by the replacement of an enzyme sensitive ester bond with a stable bond selected from an amide, N-methyl amide, enamine and sulfonamide bond |
| 01/30/2007 | US7169752 Covalently bonding at 6' position and 14' position of oxycodone a single amino acid or oligopeptide of 12 or fewer amino acids; when delivered at proper dosage composition provides therapeutic activity similar to that of parent active agent; when delivered at higher dose potential for overdose is reduced |
| 01/30/2007 | US7169574 Fluorescence detection of proteases or peptidases |
| 01/30/2007 | CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination |
| 01/25/2007 | WO2007010989A1 Neuronal differentiation-inducing peptide and use thereof |
| 01/25/2007 | WO2007010128A1 Target vector with activable imaging function |
| 01/25/2007 | WO2007009894A2 Peptides for use in the treatment of obesity |
| 01/25/2007 | WO2006130022A8 Modulation of ovulation by agonists and antagonists of bmprii |